← Open Payments lookup

KIMBERLY BUZZELLI: Open Payments

NPI 1063794212 · LYNCHBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,942 in 116 payments from 10 companies in 2025. Trend: 2023 $559 · 2024 $1,235 · 2025 $1,942

Food & beverage: $1,942
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)49$520
Neurocrine BioSciences, Inc.25$388
Otsuka America Pharmaceutical, Inc.11$283
Lundbeck LLC8$174
Janssen Pharmaceuticals, Inc6$172
Vanda Pharmaceuticals Inc.6$162
E.R. Squibb & Sons, L.L.C.3$107
ABBVIE INC.4$59
Alkermes, Inc.3$47
Teva Pharmaceuticals USA, Inc.1$31

Products named: CAPLYTA, INGREZZA, ABILIFY MAINTENA, REXULTI, INVEGA SUSTENNA, COBENFY, HETLIOZ, FANAPT.

Industry payments across VA — which companies pay providers there.